Procaps Group - PROC Price Chart

Procaps Group S.A. (PROC) acts as a pioneer in creating advanced shells for vitamins and medications, enhancing component bioavailability through precise chemical engineering. The business model relies on CDMO services, where high capacity utilization reduces unit costs via operating leverage. The current figure is 1.01. The price trend underscores the success of deliveries to Latin America and the implemented optimization of financial reporting.

Market Price: Procaps Group Corp (PROC) for 07/04/2022 - 02/16/2025

Procaps Group - analytical breakdowns and key metrics (PROC)

- stock value and consensus price forecast:

Price Chart Procaps Group S.A.|PROC - Forecast Levels Chart

- issuer market value details:

Market Value Procaps Group S.A.|PROC - Value Adjusted for Debt and Cash

- balance sheet equity data:

Net Assets per Single Share Procaps|PROC - Total Stockholders' Equity|Market Capitalization to Book Value Ratio procapsgroup.com|PROC - Cumulative Company Assets

- debt burden and liquidity indicators:

- company profitability and valuation multiples indicators:

PROC - Net Income|Projected Future Earnings Procaps Group S.A.|PROC - P/E Multiple|Projected Price to Earnings Procaps|PROC - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Procaps Group S.A.|PROC - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Procaps|PROC - Earnings per share for the last four quarters|Quarterly EPS earnings growth procapsgroup.com|PROC - Earnings per share increase in current year|Earnings growth forecast for next year Procaps Group S.A.

Fundamental valuation:Procaps Group S.A.

The price reflects the market capitalization and the business's ability to generate long-term value, where the trend slope serves as an indicator of scaling efficiency and the growth rate of shareholder equity. The stock price trajectory of Procaps Group S.A. (PROC) demonstrates a balance between the Miski family's ambitions for international expansion in the softgel sector and market concerns regarding the quality of corporate governance.

Analysis of competing companies